18 2.2.1. Première consultation : prise de la mifepristone, . ,
Review of medical abortion using mifepristone in combination with a prostaglandin analogue, Contraception, vol.74, issue.1, pp.66-86, 2006. ,
DOI : 10.1016/j.contraception.2006.03.018
Un recours moindre à l'IVG, mais plus souvent répété. Populations & Sociétés HAS-Haute Autorité de Santé. Recommandations de bonne pratique: Interruption volontaire de grossesse par méthode médicamenteuse First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review, BIBLIOGRAPHIE 1. Vilain Annick. Les interruptions volontaires de grossesse en 2012, 2010. ,
Medical methods for first trimester abortion, Cochrane Database Syst Rev, issue.11, p.2855, 2011. ,
Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days, Contraception, vol.61, issue.1, 2000. ,
DOI : 10.1016/S0010-7824(99)00119-5
Effects of misoprostol on uterine contractility following different routes of administration, Human Reproduction, vol.19, issue.1, 2004. ,
DOI : 10.1093/humrep/deh005
CNGOF. Etat des lieux et expertise de l'usage hors AMM du misoprostol en gynécologie-obstétrique: travail du CNGOF [Misoprostol: offlabel use in the first trimester of pregnancy (spontaneous abortion, and voluntary medical termination of pregnancy)], J Gynécologie Obstétrique Biol Reprod Feb, vol.1943, issue.12, pp.81-85, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01482637
Early Pregnancy Termination with Mifepristone and Misoprostol in the United States, New England Journal of Medicine, vol.338, issue.18, pp.1241-1248, 1998. ,
DOI : 10.1056/NEJM199804303381801
Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy, Contraception, vol.66, issue.4, pp.247-50, 2002. ,
DOI : 10.1016/S0010-7824(02)00366-9
Two Distinct Oral Routes of Misoprostol in Mifepristone Medical Abortion, Eur J Contracept Reprod Health Care Off J Eur Soc Contracept, pp.1303-1313, 2008. ,
DOI : 10.1097/AOG.0b013e31818d8eb4
Twopill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol, Contraception, 2009. ,
A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation, Human Reproduction, vol.18, issue.11, pp.84-90, 2003. ,
DOI : 10.1093/humrep/deg475
Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases, BJOG: An International Journal of Obstetrics and Gynaecology, vol.99, issue.2, pp.1281-1290, 2002. ,
DOI : 10.1016/S0010-7824(00)00090-1
WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy, BJOG Int J Obstet Gynaecol, 2003. ,
Endometrial thickness following medical abortion is not predictive of subsequent surgical intervention, Ultrasound in Obstetrics and Gynecology, vol.114, issue.1, pp.104-113, 2009. ,
DOI : 10.1002/uog.6404
Controversies in family planning: retained products of conception, Contraception, vol.86, issue.5, pp.438-480, 2012. ,
DOI : 10.1016/j.contraception.2012.04.003
Ultrasound evaluation of the endometrium after medical termination of pregnancy Retained products of conception: spectrum of color Doppler findings, Obstet Gynecol J Ultrasound Med Off J Am Inst Ultrasound Med, vol.103528, issue.18, pp.871-876, 2004. ,
Physiologic, Histologic, and Imaging Features of Retained Products of Conception, RadioGraphics, vol.33, issue.3, pp.781-96 ,
DOI : 10.1148/rg.333125177
Results of a 4-year study on 15,447 medical abortions provided by privately practicing general practitioners and gynecologists in France, Contraception, vol.87, issue.1, pp.45-50, 2013. ,
DOI : 10.1016/j.contraception.2012.06.006
Verifying the effectiveness of medical abortion; ultrasound versus hCG testing, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.109, issue.2, 2003. ,
DOI : 10.1016/S0301-2115(03)00012-5
Can mifepristone medical abortion be simplified? A review of the evidence and questions for future research. Contraception, 2007. ,
Comparison of medical abortion follow-up with serum human chorionic gonadotropin testing and in-office assessment, Contraception, vol.85, issue.4, pp.402-409 ,
DOI : 10.1016/j.contraception.2011.09.007
Alternatives to a routine follow-up visit for early medical abortion, Obstet Gynecol, 2010. ,
Medical abortion, Contraception, vol.68, issue.4, pp.247-51, 2003. ,
DOI : 10.1016/S0010-7824(03)00175-6
What is the right timing for ultrasound evaluation after pregnancy termination with mifepristone?, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.189, pp.24-30 ,
DOI : 10.1016/j.ejogrb.2015.03.018
Expectant management of incomplete abortion in the first trimester, International Journal of Gynecology & Obstetrics, vol.17, issue.(6), pp.35-43, 2009. ,
DOI : 10.1016/j.ijgo.2009.02.018
Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days, Contraception, vol.91, issue.4, pp.269-73 ,
DOI : 10.1016/j.contraception.2015.01.005
The efficacy of medical abortion: a meta-analysis, Contraception, vol.61, issue.1, pp.29-40, 2000. ,
DOI : 10.1016/S0010-7824(99)00115-8
Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion. Contraception, 2001. ,
Flexible mifepristone and misoprostol administration interval for first-trimester medical termination, Contraception, vol.81, issue.4, pp.269-74, 2010. ,
DOI : 10.1016/j.contraception.2009.09.007
Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost, Contraception, vol.62, issue.6, pp.297-303, 2000. ,
DOI : 10.1016/S0010-7824(00)00187-6
Significant Adverse Events and Outcomes After Medical Abortion, Obstetrics & Gynecology, vol.121, issue.1, pp.166-71, 2013. ,
DOI : 10.1097/AOG.0b013e3182755763
Infection after medical abortion: A review of the literature, Contraception, vol.70, issue.3, pp.183-90, 2004. ,
DOI : 10.1016/j.contraception.2004.04.009
Toxic Shock Associated With Clostridium sordellii and Clostridium perfringens After Medical and Spontaneous Abortion, Obstetrics & Gynecology, vol.110, issue.5, pp.1027-1060, 2007. ,
DOI : 10.1097/01.AOG.0000287291.19230.ba
Role of imaging in cases of bleeding after spontaneous or induced abortion] Comparative effectiveness, safety and acceptability of medical abortion at home and in a clinic: a systematic review Bull World Health Organ, J Gynécologie Obstétrique Biol Reprod, vol.4489, issue.55, pp.398-402, 2011. ,